Particle Sciences Granted Patent on Self Sterilizing Medical Devices
ML10
Electronic labelling of medical devices a boon for people’s safety, accuracy of instructions and environment
EU Regulatory Committee on Medical Devices approves regulation on e-instructions for use of medical devices
Abbott Enrolls First U.S. Patient in Global EXCEL Trial Comparing XIENCE to Coronary Artery Bypass Surgery
bbott’s EXCEL is the Largest Trial to Date Designed to Evaluate Optimal Treatment Strategy (Surgery or Stenting) in Patients with Unprotected Left Main Disease
Boston Scientific Begins Enrolment in NECTAR-HF Clinical Trial
Boston Scientific commences study designed to assess preliminary safety and efficacy of chronic vagal nerve stimulation in heart failure patients
Getinge to acquire Atrium
GETINGE GROUP and its subsidiary, MAQUET Cardiovascular, a global leading provider of cardiovascular technologies, has signed a definitive agreement to acquire Atrium Medical Corporation for $680 million.
MAQUET CARDIOVASCULAR RECEIVES FDA 510(K ) CLEARANCE AND CE MARK FOR ITS NEW SENSATION PLUS™ INTRA-AORTIC BALLOON CATHETER
MAQUET Cardiovascular, a leading provider of cardiovascular technologies, announced today that it has received both 510(k) clearance from the U.S. Food & Drug Administration (FDA) and CE mark approval for its new SENSATION PLUS™ 50cc 8 Fr. intra-aortic balloon catheter.
First Patients Enrolled in the U.S. OPEN Clinical Trial of the FlexStent(R) Femoropopliteal SE Stent System
Flexible Stenting Solutions Inc. has announced the successful treatment of the first two patients enrolled in the OPEN (Evaluation of Safety and Efficacy of the FlexStent(R) FemorOPopliteal Self-Expanding StENt System) clinical trial.
Women most at risk from poorly performing metal-on-metal hip replacement devices, National Joint Registry Annual Report finds
Performance for the controversial metal-on-metal (MoM) hip replacement devices continues to create cause for concern, particularly in women, according to this year’s National Joint Registry (NJR) Annual Report.
NuVasive Signs Agreement to Acquire Impulse Monitoring
NuVasive, Inc. announced today that it has executed a definitive agreement for the purchase of Impulse Monitoring, Inc., a leading Intra-Operative Monitoring provider in the United States.
Reprocessing of “single-use” devices. Pragmatism rules
Reprocessing of “single-use” devices will be allowed subject to restriction of movement of reprocessed goods.
Medtech firms need to adopt new business model according to Ernst and Young
Ernst and Young’s annual “Pulse of the Industry” report suggests that the Medtech industry will need to face up to long term challenges, both economic and regulatory.
Sapheon, Inc. Receives CE Mark Approval for New Varicose Vein Treatment
Sapheon Inc. has received CE Mark approval for its new approach to the treatment of varicose veins caused by venous reflux disease.
medlatest is changing the face of Medical Device Information Sharing
MedLatest is a news aggregation and communications website which fills an important information gap. It provides a service for companies who struggle to get their information out, and clinicians who struggle for that very information.